Int J Sports Med 2014; 35(09): 800-806
DOI: 10.1055/s-0033-1361185
Review
© Georg Thieme Verlag KG Stuttgart · New York

Implantable Cardioverter Defibrillator in Sport Participation

G. Mascia
1  Department of Medical and Surgical Critical Care, University of Florence, Florence, Italy
4  Cliniche Gavazzeni, Bergamo, Italy
,
L. Di Biase
2  St. David’s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, United States
5  Albert Einstein College of Medicine, Montefiore Hospital, Bronx, NY, United States
7  Department of Biomedical Engineering, University of Texas, Austin, Texas, USA
8  Department of Cardiology, University of Foggia, Foggia, Italy
,
G. Galanti
3  Sports Medicine Department, University of Florence, Florence, Italy
,
A. Natale
2  St. David’s Medical Center, Texas Cardiac Arrhythmia Institute, Austin, United States
6  Division of Cardiology, Stanford University, Palo Alto, California, United States
7  Department of Biomedical Engineering, University of Texas, Austin, Texas, USA
9  California Pacific Medical Center, San Francisco, California, USA
10  Heart and Vascular Center, Case Western Reserve University, Cleveland, Ohio, USA
11  Interventional Electrophysiology, Scripps Clinic, La Jolla, California, USA
,
L. Padeletti
1  Department of Medical and Surgical Critical Care, University of Florence, Florence, Italy
4  Cliniche Gavazzeni, Bergamo, Italy
› Author Affiliations
Further Information

Publication History



accepted after revision 24 October 2013

Publication Date:
15 April 2014 (eFirst)

Abstract

Although athletic participation lowers cardiovascular risk and improves quality of life, it may represent a hazard in high-risk group athletes such as those with cardiac abnormalities receiving an implantable cardioverter defibrillator (ICD). ICD sports participants are exposed to the potential risk of inappropriate shocks due to sinus tachycardia and other supraventricular arrhythmias during exertion as well as device injury. The safety of athletic participation of ICD-patients is not completely defined and ICD efficacy in interrupting malignant arrhythmias during intense exercise is partly unknown. This explains difficulties in current recommendations made by physicians, given the associated potentially ischemic, autonomic and metabolic conditions. The scope of this review is to underline specific considerations including potential risks and recommendations for athletic participation in this patient-group.